Kindrik Partners is pleased to have advised digital B2B pharmacy platform SwipeRx on its US$27 million series B funding round led by MDI Ventures. Other investors in the round included the Bill & Melinda Gates Foundation, Johnson & Johnson Impact Ventures and Susquehanna International Group (SIG).

SwipeRx, formerly known as mClinica, was founded with the goal of providing tech-based solutions to issues facing pharmacies in Southeast Asia. SwipeRx pioneered the community-driven commerce model that unites the fragmented pharmacy channel on a single platform enabling them to access all the information, education and medicines they need. From online education, to centralised purchasing and logistics, to financing, SwipeRx caters to the critical needs of pharmacies.

Operating across Indonesia, the Philippines, Vietnam, Malaysia, Thailand and Cambodia, SwipeRx’s intends to further scale its growing network of pharmacies, expand specialised healthcare logistics to fulfil B2B commerce, accelerate its tech innovation and recruit talent

Partner Lee Bagshaw says:

“Pharmaceutical networks in Southeast Asia have long struggled with fragmentation, but SwipeRx’s platform is innovating how the industry operates via an innovative community-driven commerce model. We’re delighted to have advised the company on their latest financing and look forward to seeing how their innovation continues to transform the delivery of healthcare and pharmaceutical services.”